We want to introduce the concept of using syndromic surveillance data to assess disease seriousness of COVID-19, directly relating the results from clinical studies and case series on COVID-19 pneumonia patients to the situation as it is observed in pneumonia patients at the beginning of seasonal influenza epidemics.